Bionano Genomics, Inc.
BNGO
$1.12
-$0.04-3.45%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 28.51M | 28.72M | 27.43M | 28.46M | 30.78M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 28.51M | 28.72M | 27.43M | 28.46M | 30.78M |
| Cost of Revenue | 15.32M | 15.52M | 26.04M | 27.97M | 30.40M |
| Gross Profit | 13.18M | 13.20M | 1.39M | 494.00K | 380.00K |
| SG&A Expenses | 35.15M | 38.19M | 38.59M | 41.80M | 52.50M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 61.85M | 65.33M | 78.12M | 87.16M | 107.69M |
| Operating Income | -33.34M | -36.61M | -50.70M | -58.70M | -76.92M |
| Income Before Tax | -26.33M | -38.56M | -74.29M | -83.64M | -111.98M |
| Income Tax Expenses | 66.00K | 32.00K | 42.00K | 58.00K | 33.00K |
| Earnings from Continuing Operations | -26.40 | -38.59 | -74.33 | -83.70 | -112.02 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -26.40M | -38.59M | -74.33M | -83.70M | -112.02M |
| EBIT | -33.34M | -36.61M | -50.70M | -58.70M | -76.92M |
| EBITDA | -23.81M | -27.02M | -37.85M | -45.25M | -62.89M |
| EPS Basic | -5.51 | -16.96 | -46.29 | -58.71 | -93.30 |
| Normalized Basic EPS | -3.44 | -7.76 | -16.79 | -26.06 | -44.54 |
| EPS Diluted | -5.51 | -16.96 | -46.29 | -58.71 | -93.30 |
| Normalized Diluted EPS | -3.44 | -7.76 | -16.79 | -26.06 | -44.54 |
| Average Basic Shares Outstanding | 21.77M | 13.12M | 9.21M | 6.90M | 5.08M |
| Average Diluted Shares Outstanding | 21.77M | 13.12M | 9.21M | 6.90M | 5.08M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |